CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1-2 Study of the Combination of Escalated Total Bone Marrow Irradiation (TBMI) by Helicoidal Tomotherapy and a Fixed High-dose Melphalan (140 mg/m²) Followed by Peripheral Stem Cell Rescue (PSC) in First Relapsed Multiple Myeloma.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01794572
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:49.861583+00:00
Published At: 2025-12-12T00:00:00+00:00
Record Updated At: 2025-12-12
Results Posted At: 2025-12-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Multiple Myeloma in Relapse"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-12-12"
protocolSection.identificationModule.nctId: "NCT01794572"
protocolSection.identificationModule.officialTitle: "Phase 1-2 Study of the Combination of Escalated Total Bone Marrow Irradiation (TBMI) by Helicoidal Tomotherapy and a Fixed High-dose Melphalan (140 mg/m\u00b2) Followed by Peripheral Stem Cell Rescue (PSC) in First Relapsed Multiple Myeloma."
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-12-12"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.